← Open Payments lookup

JOHN MILNER: Open Payments

NPI 1558026021 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,181 in 53 payments from 14 companies in 2025. Trend: 2023 $71 · 2024 $877 · 2025 $1,181

Food & beverage: $1,097Education: $84
CompanyPaymentsAmount
ABBVIE INC.23$231
Salix Pharmaceuticals, a division of Bausch Health US, LLC7$154
Novo Nordisk Inc1$125
GENZYME CORPORATION1$122
Janssen Biotech, Inc.2$106
Takeda Pharmaceuticals U.S.A., Inc.4$93
Aimmune Therapeutics, Inc.3$91
Gilead Sciences, Inc.2$59
Regeneron Healthcare Solutions, Inc.2$57
Ardelyx, Inc.2$49

Products named: DUPIXENT, Wegovy, XIFAXAN, TREMFYA, ENTYVIO, ZENPEP, LINZESS, SKYRIZI.

Industry payments across CA — which companies pay providers there.